» Articles » PMID: 20035060

Inhibition of CD36-dependent Phagocytosis by Prostaglandin E2 Contributes to the Development of Endometriosis

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2009 Dec 26
PMID 20035060
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Dysfunction in macrophage-mediated phagocytosis of aberrant cells that undergo retrograde transport to the peritoneal cavity is considered an important factor in the development of endometriosis. However, the mechanisms responsible for the loss of function of macrophages remain largely unknown. Herein, we report that prostaglandin (PG) E(2), via the EP2 receptor-dependent signaling pathway, inhibits the expression of CD36 in peritoneal macrophages, resulting in reduced phagocytic ability. PGE(2)-mediated inhibition of macrophage phagocytic capability was restored by ectopic expression of CD36. Treatment with PGE(2) inhibited CD36-dependent phagocytosis of peritoneal macrophages and increased the number and size of endometriotic lesions in mice. In contrast, blockade of PGE(2) production by cyclooxygenase inhibitors enhanced the phagocytic ability of peritoneal macrophages and reduced endometriotic lesion formation. Taken together, our findings reveal a potential mechanism of immune dysfunction during endometriosis development and may contribute to the design of an effective prevention/treatment regimen.

Citing Articles

Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives.

Tang H, Lin T, Wu M, Tsai S Reprod Med Biol. 2024; 23(1):e12588.

PMID: 38854774 PMC: 11157498. DOI: 10.1002/rmb2.12588.


Donor Mesenchymal Stem Cells Program Bone Marrow, Altering Macrophages, and Suppressing Endometriosis in Mice.

Habata S, Mamillapalli R, Ucar A, Taylor H Stem Cells Int. 2023; 2023:1598127.

PMID: 37545483 PMC: 10403325. DOI: 10.1155/2023/1598127.


Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis.

Ganesh T J Med Chem. 2023; 66(14):9313-9324.

PMID: 37458373 PMC: 10388357. DOI: 10.1021/acs.jmedchem.3c00655.


Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis.

Li J, He Y, Qu Y, Ren C, Wang X, Cheng Y Front Immunol. 2023; 14:1115504.

PMID: 37143676 PMC: 10151653. DOI: 10.3389/fimmu.2023.1115504.


Macrophages and small extracellular vesicle mediated-intracellular communication in the peritoneal microenvironment: Impact on endometriosis development.

Wang Y, Dragovic R, Greaves E, Becker C, Southcombe J Front Reprod Health. 2023; 5:1130849.

PMID: 37077181 PMC: 10106708. DOI: 10.3389/frph.2023.1130849.


References
1.
Hsu C, Lu C, Huang B, Wu M, Tsai S . Cyclic adenosine 3',5'-monophosphate response element-binding protein and CCAAT/enhancer-binding protein mediate prostaglandin E2-induced steroidogenic acute regulatory protein expression in endometriotic stromal cells. Am J Pathol. 2008; 173(2):433-41. PMC: 2475780. DOI: 10.2353/ajpath.2008.080199. View

2.
Tamura M, Sebastian S, Yang S, Gurates B, Fang Z, Bulun S . Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab. 2002; 87(7):3263-73. DOI: 10.1210/jcem.87.7.8594. View

3.
Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P . Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod. 1999; 14(12):2944-50. DOI: 10.1093/humrep/14.12.2944. View

4.
Wu M, Wang C, Lin C, Chen L, Chang W, Tsai S . Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells. J Clin Endocrinol Metab. 2004; 90(1):286-95. DOI: 10.1210/jc.2004-1612. View

5.
Dunn G, Old L, Schreiber R . The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004; 21(2):137-48. DOI: 10.1016/j.immuni.2004.07.017. View